Companies: 10,795·Total market cap: $144.5T
Kezar Life Sciences, Inc.

Kezar Life Sciences, Inc.

KZRNASDAQHealthcare
$7.29
+$0.00(+0.00%)
Market Cap$53856333
P/E Ratio—
52W High$7.55
52W Low$3.53
SEC Filings

Kezar Life Sciences, Inc. (KZR) SEC Filings & 10-K Annual Reports

SEC EDGAR regulatory submissions (10-K, 10-Q, 8-K), latest forms, and full filing history — quick links to financials and earnings below.

SEC EDGAR · data.sec.gov · CIK 0001645666 · KZR · NASDAQ · as of Jun 9, 2026

Filing snapshot

487
Total Filings
SCHEDULE 13G/A
Latest Form
2026-05-28
Most Recent
2018
Filing Since
FinancialsEarningsView All on EDGAR

Source: SEC EDGAR (data.sec.gov) · CIK 0001645666 · Updated hourly · Not investment advice

Latest Annual Report

10-K · Annual ReportFY
Filed Date
2026-04-30
Fiscal Year End
Apr 30, 2026
Accession No.
0001628280-26-028914
Primary Document
kzr-20251231.htm
View on SEC EDGARDownload PDFFiling Index
Source: data.sec.gov · CIK 0001645666 · Accession 0001628280-26-028914

Latest Key Filings

10-QQuarterly Report
10-Q
2026-05-11
View 10-Q on SEC
8-KCurrent Report
8-K
2026-05-11Material Event
View 8-K on SEC
Form 4Insider Activity
Ownership Change Disclosures

Executive & director trade disclosures. Full buy/sell sentiment analysis on the dedicated tab.

View Insider Trades Tab

SEC Filing History

Hide Form 4 / 144
SCHEDULE 13G/ASCHEDULE 13G/A
SCHEDULE 13G/A
2026-05-28
View
15-12G15-12G
15-12G
2026-05-21
View
EFFECTEFFECT
EFFECT
2026-05-14
View
SCHEDULE 13D/ASCHEDULE 13D/A
SCHEDULE 13D/A
2026-05-13
View
SCHEDULE 13G/ASCHEDULE 13G/A
SCHEDULE 13G/A
2026-05-12
View
SCHEDULE 13G/ASCHEDULE 13G/A
SCHEDULE 13G/A
2026-05-12
View
S-8 POSS-8 POS
S-8 POS
2026-05-11
View
S-8 POSS-8 POS
S-8 POS
2026-05-11
View
S-8 POSS-8 POS
S-8 POS
2026-05-11
View
S-8 POSS-8 POS
S-8 POS
2026-05-11
View
S-8 POSS-8 POS
S-8 POS
2026-05-11
View
S-8 POSS-8 POS
S-8 POS
2026-05-11
View
S-8 POSS-8 POS
S-8 POS
2026-05-11
View
S-8 POSS-8 POS
S-8 POS
2026-05-11
View
POS AMPOS AM
POS AM
2026-05-11
View
Showing 1–15 of 321 filingsForm 4 / 144 hidden· 487 total in EDGAR

About SEC Filings & 10-K Annual Reports

Data source: SEC EDGAR (data.sec.gov)  |  Updated: Hourly  |  CIK: 0001645666  |  Exchange: NASDAQ · Healthcare

Kezar Life Sciences, Inc. (NASDAQ: KZR) has submitted 487 documents to the U.S. Securities and Exchange Commission (SEC) since its IPO in 2018. As a Healthcare sector company with CIK 0001645666, all filings are publicly accessible via the EDGAR database at no cost.

The annual 10-K report is Kezar Life Sciences, Inc.'s most comprehensive regulatory disclosure. The most recent Kezar Life Sciences, Inc. 10-K was filed on 2026-04-30 for fiscal year ending 2026. Historical KZR 10-K annual reports are available from 2015 through 2026.

Investors researching Kezar Life Sciences, Inc. SEC filings can access 10-K annual reports, quarterly 10-Q reports, material event 8-K filings, and proxy statements directly from the links above. All documents are sourced from the official SEC EDGAR system.

Source: SEC EDGAR · data.sec.gov · SEC Form 10-K · SEC Form 10-Q · SEC Form 8-K2026-06-09
Related Companies SEC Filings — Healthcare
XFOR SEC Filings →MRSN SEC Filings →OKUR SEC Filings →PDSB SEC Filings →XLO SEC Filings →FGEN SEC Filings →ATNM SEC Filings →ALGS SEC Filings →
→ KZR Financials→ KZR Earnings→ KZR Insider Trades

Frequently Asked Questions

KZR SEC Filings · 8 questions

Kezar Life Sciences, Inc. (KZR) SEC filings are publicly available on this page and on the official SEC EDGAR database at sec.gov. You can browse all 487 filings and access original documents at no cost. Kezar Life Sciences, Inc.'s CIK is 0001645666.

KZR SEC filingsKezar Life Sciences, Inc. SEC documentsfind KZR 10-K